The role of quantitative HBsAg in patients with HBV DNA between 2000–20,000 IU/ml

被引:0
|
作者
Sibel Yıldız Kaya
Bilgül Mete
Abdurrahman Kaya
Ilker Inanç Balkan
Neşe Saltoglu
Ömer Fehmi Tabak
机构
[1] Sungurlu State Hospital,Department of Infectious Disease
[2] Istanbul University-Cerrahpasa,Department of Infectious Disease, Medical School of Cerrahpasa
[3] Istanbul Training and Research Hospital,Department of Infectious Disease
来源
关键词
Quantitative; HBsAg; Hepatitis B; Chronic infection; Chronic hepatitis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:647 / 653
页数:6
相关论文
共 50 条
  • [1] The role of quantitative HBsAg in patients with HBV DNA between 2000-20,000 IU/ml
    Yildiz Kaya, Sibel
    Mete, Bilgul
    Kaya, Abdurrahman
    Balkan, Ilker Inanc
    Saltoglu, Nese
    Tabak, Omer Fehmi
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (13-14) : 647 - 653
  • [2] MOST PATIENTS WITH HBV DNA BETWEEN 2,000 AND 20,000 IU/ML OVER TIME HAVE MILD INFLAMMATION AND FIBROSIS ON LIVER BIOPSY
    McMahon, Brian J.
    Bulkow, Lisa
    Zhang, Yuhong
    Simons, Brenna
    Negus, Susan
    Homan, Chriss E.
    Livingston, Stephen
    Lau, Daryl
    HEPATOLOGY, 2011, 54 : 611A - 611A
  • [3] HBV DNA / Quantitative HBsAg Level Ratio, but Not Either Quantitative HBsAg Level or HBV DNA, Can Predict Hepatocellular Carcinoma Development in HBeAg-Negative Chronic Hepatitis Patients with HBV DNA ≥ 2000 IU/mL
    Ahn, Jem Ma
    Sinn, Dong Hyun
    Cho, Ju Yeon
    Sohn, Won
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    Yoo, Byung Chul
    HEPATOLOGY, 2014, 60 : 884A - 884A
  • [4] IS LIVER BIOPSY REQUIRED FOR ALL PATIENTS (PTS) WITH HBEAG-NEGATIVE (HBEAG-) CHRONIC HBV INFECTION AND HBV DNA <20,000 IU/ML?
    Papatheodoridis, George V.
    Manesis, Emanuel K.
    Manolakopoulos, Spilios
    Elefsiniotis, Ioannis
    Giannousis, Ioannis
    Kafiri, Georgia
    Archimandritis, Athanasios J.
    HEPATOLOGY, 2008, 48 (04) : 681A - 682A
  • [5] Lamivudine Monotherapy-Based cART Is Efficacious for HBV Treatment in HIV/HBV Coinfection When Baseline HBV DNA &lt;20,000 IU/mL
    Li, Yijia
    Xie, Jing
    Han, Yang
    Wang, Huanling
    Zhu, Ting
    Wang, Nidan
    Lv, Wei
    Guo, Fuping
    Qiu, Zhifeng
    Li, Yanling
    Song, Xiaojing
    Thio, Chloe L.
    Li, Taisheng
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 72 (01) : 39 - 45
  • [6] IS LIVER BIOPSY USEFUL FOR HBeAg NEGATIVE PATIENTS WITH HBV DNA BETWEEN 2000-20000 IU/mL AND NORMAL ALT?
    Berkane, S.
    Debzi, N.
    Chikhi, S.
    Afredj, N.
    Cheraitia, S.
    Guessab, N.
    Merniz, M.
    Mahiou, H.
    Aissaoui, M.
    Gougam, R. Ould
    Louahadj, O.
    Bensalem, S.
    Gourari, S.
    Younes, S. Ait
    Amir, Z. C.
    Sufan, S.
    Abassi, M.
    Nakmouche, M.
    Hanoun, D.
    Rouabhia, S.
    Asselah, F.
    Boucekkine, T.
    Asselah, H.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S167 - S167
  • [7] HBeAg negative chronic hepatitis B patients with HBV-DNA levels between 2,000-20,000IU/ml and normal aminotransferases are really inactive?
    Ergul, B.
    Utku, Ozlem Gul
    Yilmaz, Baris
    Koseoglu, Huseyin
    Oguz, D.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S504 - S505
  • [8] Correlation between HBsAg quantitative assay results and HBV DNA levels in chronic HBV
    Ganji, Azita
    Esmaeilzadeh, Abbas
    Ghafarzadegan, Kamran
    Helalat, Hoda
    Rafatpanah, Houshang
    Mokhtarifar, Ali
    HEPATITIS MONTHLY, 2011, 11 (05) : 342 - 345
  • [9] Correlation between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients
    Pete, Maria
    Ruzic, Maja
    Kovacevic, Nadica
    Petric, Vedrana
    Milosevic, Ivana
    Preveden, Tomislav
    VOJNOSANITETSKI PREGLED, 2023, 80 (07) : 555 - 560
  • [10] Relationship between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients
    Yang, Na
    Feng, Jin
    Zhou, Taicheng
    Li, Zhuoran
    Chen, Zhengyu
    Ming, Kaihua
    Liang, Guangtie
    Lei, Xiu-xia
    Xu, Bang-Lao
    JOURNAL OF MEDICAL VIROLOGY, 2018, 90 (07) : 1240 - 1245